• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族/民族对 Bypass Angioplasty Revascularization Investigation 2 Diabetes 试验中基线特征和冠状动脉粥样硬化负担的影响。

The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

机构信息

Northwestern University School of Medicine, Chicago, IL, USA.

出版信息

Am Heart J. 2011 Apr;161(4):755-63. doi: 10.1016/j.ahj.2010.12.013.

DOI:10.1016/j.ahj.2010.12.013
PMID:21473976
Abstract

OBJECTIVES

We aimed to test the impact of race/ethnicity on coronary artery disease (CAD) after adjusting for baseline risk factors.

BACKGROUND

Whether race/ethnicity remains an important determinant of the burden of CAD even among patients with long-standing type 2 diabetes (diabetes mellitus) and established CAD is unknown.

METHODS

Analysis of baseline data from the BARI 2D trial (January 1, 2001, to March 31, 2005) was performed. Myocardial jeopardy index (MJI) was evaluated by a blinded core angiographic laboratory. Multivariate regression analysis was performed to determine the independent association of race/ethnicity on the burden of CAD after adjusting for baseline risk factors. Data were collected from US and Canadian academic and community hospitals. The baseline analysis was performed on patients with long-standing diabetes and documented CAD with no prior revascularization at study entry (n = 1,331). The main outcome measure was MJI, which represents the percentage of myocardium jeopardized by significant lesions (≥50%). The secondary outcome measure was ≥2 lesions with ≥50% stenosis.

RESULTS

Risk factors varied significantly among racial/ethnic groups. Blacks were significantly more likely to be women, have no health insurance, be current smokers, have higher body mass index, have hypertension, have a longer duration of diabetes, a higher hemoglobin A(1c) level, and were more likely to be taking insulin. Their mean total, low-density lipid, and high-density lipid cholesterol levels were higher, whereas their triglycerides were lower than others. After controlling for baseline risk factors, blacks had a significantly lower burden of CAD; the adjusted MJI was 5.43 U lower (95% CI -9.13 to -1.72), and the adjusted number of lesions was 0.53 fewer (95% CI -0.88 to -0.18) in blacks compared to whites.

CONCLUSIONS

In the BARI 2D trial, self-reported race/ethnicity is associated with important differences in baseline risk factors and is a powerful predictor of the burden of CAD adjusting for such baseline differences. These findings may help direct medical intervention and resources and further investigation into the basis of racial/ethnic differences in CAD burden.

摘要

目的

本研究旨在调整基线风险因素后,检验种族/民族对冠状动脉疾病(CAD)的影响。

背景

种族/民族是否仍然是长期 2 型糖尿病(糖尿病)和已确诊 CAD 患者 CAD 负担的重要决定因素尚不清楚。

方法

对 BARI 2D 试验的基线数据(2001 年 1 月 1 日至 2005 年 3 月 31 日)进行分析。心肌危险指数(MJI)由盲法核心血管造影实验室评估。多变量回归分析用于确定在调整基线风险因素后,种族/民族与 CAD 负担之间的独立关联。数据来自美国和加拿大的学术和社区医院。基线分析纳入了长期糖尿病且研究入组时无既往血运重建的有记录 CAD 患者(n=1331)。主要观察指标为 MJI,代表有显著病变(≥50%)的心肌受损百分比。次要观察指标为≥2 个狭窄≥50%的病变。

结果

不同种族/民族的危险因素存在显著差异。黑人患者更可能为女性、无医疗保险、当前吸烟者、体重指数更高、患有高血压、糖尿病病程更长、糖化血红蛋白水平更高,且更可能使用胰岛素。他们的总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇水平更高,而甘油三酯水平更低。在控制基线风险因素后,黑人的 CAD 负担显著降低;调整后的 MJI 低 9.13-1.72 个单位(95%CI),调整后的病变数少 0.53 个(95%CI-0.88 至-0.18)。

结论

在 BARI 2D 试验中,自我报告的种族/民族与基线风险因素存在显著差异,并且是调整此类基线差异后 CAD 负担的有力预测因素。这些发现可能有助于指导医疗干预和资源,并进一步研究 CAD 负担种族/民族差异的基础。

相似文献

1
The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.种族/民族对 Bypass Angioplasty Revascularization Investigation 2 Diabetes 试验中基线特征和冠状动脉粥样硬化负担的影响。
Am Heart J. 2011 Apr;161(4):755-63. doi: 10.1016/j.ahj.2010.12.013.
2
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).旁路血管成形血运重建研究2糖尿病试验(BARI 2D)中的基线冠状动脉造影结果。
Am J Cardiol. 2009 Mar 1;103(5):632-8. doi: 10.1016/j.amjcard.2008.11.024. Epub 2009 Jan 12.
3
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.参加“搭桥血管成形血运重建术研究2糖尿病(BARI 2D)试验”的糖尿病和冠状动脉疾病患者的基线特征。
Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. doi: 10.1016/j.ahj.2008.05.015. Epub 2008 Jul 31.
4
Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).在接受当代药物治疗(无论是否及时血运重建)的 2 型糖尿病合并冠心病患者中,性别对临床表现和结局的影响:来自 BARI 2D 试验(Bypass Angioplasty Revascularization Investigation 2 Diabetes)的报告。
J Am Coll Cardiol. 2013 Apr 30;61(17):1767-76. doi: 10.1016/j.jacc.2013.01.062. Epub 2013 Feb 28.
5
Race/ethnic disparities in risk factor control and survival in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.在旁路血管成形术再血管化调查 2 型糖尿病(BARI 2D)试验中,种族/民族差异对危险因素控制和生存的影响。
Am J Cardiol. 2013 Nov 1;112(9):1298-305. doi: 10.1016/j.amjcard.2013.05.071. Epub 2013 Aug 1.
6
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial).糖尿病合并冠心病患者的性别、临床症状和血管造影结果(来自旁路血管成形术再血管化研究 [BARI] 2 型糖尿病试验)。
Am J Cardiol. 2011 Apr 1;107(7):980-5. doi: 10.1016/j.amjcard.2010.11.020. Epub 2011 Jan 26.
7
Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial.过氧化物酶体增殖物激活受体通路基因多态性与 2 型糖尿病患者旁路血管成形术血运重建调查 2 型糖尿病试验中冠状动脉疾病程度的关系。
Circulation. 2011 Sep 27;124(13):1426-34. doi: 10.1161/CIRCULATIONAHA.111.029173. Epub 2011 Sep 12.
8
Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).2型糖尿病患者严重冠状动脉狭窄与胰岛素或噻唑烷二酮类药物使用的关系(来自旁路血管成形术血运重建调查2糖尿病研究)
Am J Cardiol. 2009 Jul 1;104(1):52-8. doi: 10.1016/j.amjcard.2009.02.046. Epub 2009 May 13.
9
Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.入组 BARI 2D 试验时的健康保险状况以及糖尿病和冠状动脉疾病危险因素的控制。
Diabetes Educ. 2010 Sep-Oct;36(5):774-83. doi: 10.1177/0145721710374653. Epub 2010 Jun 28.
10
Racial differences in long-term survival among patients with coronary artery disease.种族差异对冠心病患者长期生存的影响。
Am Heart J. 2010 Oct;160(4):744-51. doi: 10.1016/j.ahj.2010.06.014.

引用本文的文献

1
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.
2
An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).综合生物标志物风险评分可预测近期心肌梗死和死亡的高危风险:来自 BARI 2D(旁路血管成形术血运重建调查 2 型糖尿病)的研究结果。
J Am Heart Assoc. 2017 Jul 3;6(7):e003587. doi: 10.1161/JAHA.116.003587.
3
Race/ethnic disparities in risk factor control and survival in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.
在旁路血管成形术再血管化调查 2 型糖尿病(BARI 2D)试验中,种族/民族差异对危险因素控制和生存的影响。
Am J Cardiol. 2013 Nov 1;112(9):1298-305. doi: 10.1016/j.amjcard.2013.05.071. Epub 2013 Aug 1.
4
Mortality among low-income African Americans and whites with diabetes.低收入非裔美国人和白人与糖尿病相关的死亡率。
Diabetes Care. 2012 Nov;35(11):2293-9. doi: 10.2337/dc11-2495. Epub 2012 Aug 21.